(Q45735852)

15 December 2017

title

A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy (English)

1 reference

15 December 2017

R H Haubrich

1

1 reference

15 December 2017

J S Currier

2

1 reference

15 December 2017

D N Forthal

3

1 reference

15 December 2017

G Beall

4

1 reference

15 December 2017

C A Kemper

5

1 reference

15 December 2017

D Johnson

6

1 reference

15 December 2017

M P Dubé

7

1 reference

15 December 2017

J Hwang

8

1 reference

15 December 2017

J M Leedom

9

1 reference

15 December 2017

J Tilles

10

1 reference

15 December 2017

J A McCutchan

11

1 reference

15 December 2017

California Collaborative Treatment Group

12

1 reference

15 December 2017

language of work or name

English

0 references

publication date

5 September 2001

1 reference

Clinical Infectious Diseases

15 December 2017

published in

1 reference

15 December 2017

volume

33

1 reference

15 December 2017

issue

7

1 reference

15 December 2017

page(s)

1060-1068

1 reference

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

15 December 2017

cites work

1 reference

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

21 January 2018

1 reference

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels

21 January 2018

1 reference

HIV viral load markers in clinical practice

21 January 2018

1 reference

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

21 January 2018

1 reference

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 January 2018

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

21 January 2018

1 reference

Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team.

21 January 2018

1 reference

Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team

21 January 2018

1 reference

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy

21 January 2018

1 reference

Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.

21 January 2018

1 reference

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

21 January 2018

1 reference

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

21 January 2018

1 reference

Both Serum HIV Type 1 RNA Levels and CD4+ Lymphocyte Counts Predict Clinical Outcome in HIV Type 1-Infected Subjects with 200 to 500 CD4+ Cells per Cubic Millimeter

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/322636

1 reference

15 December 2017

1 reference